Targeted reduction in body mass index is a worthwhile risk reduction strategy for prostate cancer

Research output: Contribution to journalEditorial

1 Citation (Scopus)
Original languageEnglish (US)
Pages (from-to)349
Number of pages1
JournalJAMA oncology
Volume1
Issue number3
DOIs
StatePublished - Jun 1 2015
Externally publishedYes

Fingerprint

Health Status Disparities
Anticarcinogenic Agents
Risk Reduction Behavior
Vitamin E
African Americans
Prostatic Neoplasms
Body Mass Index
Obesity

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Targeted reduction in body mass index is a worthwhile risk reduction strategy for prostate cancer. / Thomas, Charles.

In: JAMA oncology, Vol. 1, No. 3, 01.06.2015, p. 349.

Research output: Contribution to journalEditorial

@article{10d465e89ae04c62b26471ca1cc645b6,
title = "Targeted reduction in body mass index is a worthwhile risk reduction strategy for prostate cancer",
author = "Charles Thomas",
year = "2015",
month = "6",
day = "1",
doi = "10.1001/jamaoncol.2015.0514",
language = "English (US)",
volume = "1",
pages = "349",
journal = "JAMA oncology",
issn = "2374-2437",
publisher = "American Medical Association",
number = "3",

}

TY - JOUR

T1 - Targeted reduction in body mass index is a worthwhile risk reduction strategy for prostate cancer

AU - Thomas, Charles

PY - 2015/6/1

Y1 - 2015/6/1

UR - http://www.scopus.com/inward/record.url?scp=84994509433&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84994509433&partnerID=8YFLogxK

U2 - 10.1001/jamaoncol.2015.0514

DO - 10.1001/jamaoncol.2015.0514

M3 - Editorial

C2 - 26181185

AN - SCOPUS:84994509433

VL - 1

SP - 349

JO - JAMA oncology

JF - JAMA oncology

SN - 2374-2437

IS - 3

ER -